The NOD-like receptor family, pyrin domain containing 3 (NLRP3) inflammasome is a multiprotein complex consisting of a receptor, an adaptor protein, and procaspase-1 that induces the secretion of the mature form of IL-1b in response to microbial infection and danger signals. Activation of the NLRP3 inflammasome induced by endogenous danger signal molecules is closely linked to the development and progress of chronic inflammatory diseases. The oxidation of phospholipids occurs upon cellular stress and damage, resulting in the accumulation of oxidized phosphatidylcholines (oxPAPC) such as 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-phosphocholine (POVPC) at inflammatory sites. In this study, we investigated whether oxidized phosphatidylcholine induces the activation of NLRP3 inflammasome in macrophages, leading to the secretion of IL-1b. POVPC induced the degradation of procaspase-1 to caspase-1(p10), the cleavage of pro-IL-1b to IL-1b, and oligomerization of ASC in primary mouse bone marrow-derived macrophages. POVPCinduced production of caspase-1, and IL-1b was abolished in macrophages derived from NLRP3-or caspase-1-deficient mice. In an air pouch model and a peritonitis model in mice, POVPC injection resulted in the production of caspase-1(p10), IL-1b, and IL-18 in wild-type, but not in NLRP3-deficient, mice. POVPC-induced inflammasome activation was mediated by mitochondrial reactive oxygen species resulting from intracellular Ca 2+ signaling and mitochondrial destabilization. Our results demonstrate that endogenously produced oxidized phosphatidylcholines such as POVPC induce the activation of NLRP3 inflammasome, leading to the production of IL-1b in macrophages. The results provide an insight to understand how the oxidized lipids endogenously produced upon cellular stress and tissue damage contribute to the inflammatory reaction at pathologic sites.
Introduction
The inflammasome is one of the innate immune systems that mediate the production and secretion of the mature form of IL-1b, a proinflammatory cytokine that regulates a variety of physiologic and pathologic responses. Excessive IL-1b production is closely linked to chronic inflammatory diseases, including atherosclerosis, rheumatoid arthritis, gout, and diabetes [1, 2] . NLRP3 is one of the NLR family members. Once NLRP3 is activated by various stimuli, it forms an inflammasome complex of a multiprotein platform containing the adaptor protein ASC and the IL-converting enzyme procaspase-1 [3] . Procaspase-1 is cleaved to caspase-1(p10), which is an active form and processes pro-IL-1b to the biologically active form of IL-1b, so that IL-1b can be secreted to the extracellular compartment.
The stimuli to activate the NLRP3 inflammasome during infection include bacterial, viral, and fungal pathogens, such as Sendai virus, Saccharomyces cerevisiae, and Candida albicans, indicating the role in host defense against pathogen infection [3, 4] . In addition, the activation of NLRP3 inflammasome is induced by danger signals endogenously released upon cellular stress and damage, including extracellular ATP, MSU crystals, amyloid-b, and cholesterol crystals [5] . These corroborate the implication that the NLRP3 inflammasome is involved in the development and progression of chronic inflammatory diseases such as gout, Alzheimer's disease, type 2 diabetes, and atherosclerosis [1] .
Recent reports show that the activation of the inflammasome is regulated by the levels and kinds of endogenous lipids, such as oxidized LDL, cholesterol, palmitic acid, ceramide, mitochondrial cardiolipin, and 4-hydroxynonenal [6] [7] [8] [9] [10] . Phospholipids are the major components of cell membrane.
The oxidation of phospholipids occurs when the cells are activated under oxidative stress. One of the major phospholipids in plasma membrane and lipoprotein is PAPC. The sn-2 fatty acid residues in PAPC are oxidatively truncated and converted to oxPAPC, such as POVPC and PGPC [11] . Oxidation products of phospholipids have the capacity to exert proinflammatory effects [12] . Oxidized phospholipids activate monocytes and vascular smooth muscle cells, increasing the expression of proinflammatory cytokines, such as IL-1b, MCP-1, IL-8, and IL-6, that are critical for the initiation and development of chronic inflammatory diseases [11] [12] [13] [14] . The levels of oxidized phospholipids were increased in various pathologic situations, including atherosclerosis, hyperlipidemia, dyslipidemia, and nonalcoholic fatty liver disease [15, 16] . OxPAPCs, especially POVPC and PGPC accumulate at the site of oxidative stress in vivo, such as aorta of rabbit fed an atherogenic diet, plasma of hyperlipidemic mice, atherosclerotic plaques of mice and rabbits, damaged human retina, and nonalcoholic fatty liver disease [16] [17] [18] [19] [20] . These suggest that oxPAPCs could act as endogenous danger signals to induce the activation of the inflammasome. Therefore, we investigated whether an oxPAPC such as POVPC induces the activation of the NLRP3 inflammasome in macrophages leading to the secretion of IL-1b.
MATERIALS AND METHODS

Animals and cell culture
The experimental protocols were in accordance with guidelines of the Institutional Animal Care and Use Committee of the Catholic University of Korea (Permissions 2012-5-001 and 2014-007-004). C57BL/6 mice were from Orient Bio (Seoul, Korea). NLRP3-knockout mice (B6N.129-Nlrp3 tm3Hhf/J ) and caspase-1 knockout mice (B6N.129S2-Casp1 tm1Flv/J ) were purchased from The Jackson Laboratory (Bar Harbor, ME, USA). The mice were acclimated under specific pathogen-free conditions in an animal facility for at least a week before the experiments. They were housed in a room controlled for temperature (23 6 3°C) and relative humidity (40-60%).
Bone marrow was isolated from C57BL/6 mice, as has been described [21] . Isolated bone marrow cells were differentiated into macrophages in DMEM containing 10% (v/v) heat-inactivated FBS (Thermo Fisher Scientific, Carlsbad, CA, USA), 100 U/ml of penicillin, 100 mg/ml streptomycin, and 20% L929 conditioned medium for 7 d. The adherent cells were used as BMDMs. Cells were maintained at 37°C in a 5% CO 2 /air environment.
Reagents
Purified LPS from Escherichia coli was obtained from List Biological Laboratories, Inc. (Campbell, CA, USA) and dissolved in endotoxin-free water from Sigma-Aldrich (St. Louis, MO, USA). POVPC, KOdiA-PC, and PGPC were purchased from Cayman Chemical (Ann Arbor, MI, USA 
Immunoblot analysis
BMDMs were primed with LPSs [100 ng/ml for POVPC, ATP, or poly(dA:dT) and 500 ng/ml for MSU] for 4 h. The cells were treated with POVPC in DMEM+0.25% FBS. Culture supernatants of BMDMs were concentrated by methanol-chloroform protein precipitation. Cell culture supernatant was mixed with methanol:chloroform at a 4:4:1 (cell culture supernatant/ methanol/chloroform) ratio. The mixture was vortexed and centrifuged for 10 min at 20,000 g. The clear upper phase was discarded, and methanol was added to the interphase. The mixture was centrifuged for 10 min at 20,000 g, and the liquid phase was removed. The protein pellet was dried, resuspended with sample loading buffer (0.0625 M Tris-HCl, 10% glycerol, 2.5% SDS, 5% 2-ME, and 0.01% bromophenol blue), and incubated for 30 min at 37°C. Equal volumes of samples were resolved on SDS-PAGE and electrotransferred to PVDF membrane. The membranes were blocked to prevent any nonspecific binding and incubated with the corresponding primary antibody and the secondary antibody conjugated to horseradish peroxidase. The bands were visualized with the ECL-based detection method.
Determination of ASC oligomerization
Insoluble ASC oligomers were isolated from cell lysates and incubated with the protein cross-linking agent disuccinimidyl suberate [22] . The samples were resolved on SDS-PAGE and processed for immunoblot analysis.
Confocal microscopy analysis
Confocal microscopy analysis was performed by a published method [23] . In brief, BMDMs were fixed with cold methanol and stained with anti-ASC antibody and FITC-conjugated secondary antibody for detection of ASC oligomer. Images were acquired with an LSM710 confocal microscope and analyzed by Zen2010 software (Zeiss, Oberkochen, Germany).
Air pouch mouse model
An air pouch was produced by subcutaneous injection of 5 ml of sterile air into the back of the C57BL/6 mouse, followed by injection of 3 ml of sterile air after 3 d. On day 4, POVPC (600 mg suspended in 1 ml sterile PBS) was injected into the air pouch. After 6 h, the air pouch fluids were harvested with 2 ml of PBS containing 5 mM of EDTA. The air pouch fluids were centrifuged at 12,000 rpm for 5 min, the supernatants were analyzed for cytokines by ELISA, and the pellets were analyzed for caspase-1 and IL-1b by immunoblot analysis.
Mouse peritonitis model
Peritonitis was induced by intraperitoneal injection of POVPC (600 mg) or MSU crystals (3 mg) suspended in 1 ml sterile PBS. After 6 h, peritoneal cavities were washed with 2 ml of PBS containing 5 mM EDTA. The lavage fluids were harvested and analyzed for cytokines by ELISA.
Determination of mitochondrial ROS production
Mitochondrial superoxide production was determined with MitoSOXRed (Thermo Fisher Scientific). BMDMs were incubated with 4 mM MitoSOX-Red for 15 min at 37°C. The cells were washed gently 3 times with PBS. MitoSOX-Red fluorescence was measured at 580 nm after excitation at 510 nm with SpectraMaxM5 (Molecular Devices, Sunnyvale, CA, USA). 
Statistical analysis
Data are expressed as means 6 SEM. Comparison of data between groups was made with 1-way ANOVA, followed by Tukey's multiple-range test. Results were significant when P , 0.05.
RESULTS
OxPOVPC induces the production of caspase-1 and IL-1b in macrophages
To investigate whether POVPC induces activation of the inflammasome, LPS-primed BMDMs were treated with POVPC and the degradation of procaspase-1 to caspase-1(p10) and the cleavage of pro-IL-1b to IL-1b were determined. POVPC at 50 and 100 mg/ml induced the degradation of procaspase-1 to caspase-1(p10) and the cleavage of pro-IL-1b to IL-1b in BMDMs, as determined by immunoblot analysis (Fig. 1A) . ELISA confirmed that POVPC induced the secretion of IL-1b in BMDMs (Fig. 1B) . POVPC-induced production of caspase-1(p10) and IL-1b occurred from 1 h of incubation (Fig. 1C, D) . Oligomerization of ASC is another hallmark of inflammasome activation. POVPC induced oligomerization of ASC in BMDMs, as determined by immunoblot and confocal microscopic analysis ( Fig. 2A, B) . These results show that POVPC induces the activation of the inflammasome in macrophages.
We examined whether POVPC would induce pyroptosis (inflammasome-mediated cell death) by measuring lactate dehydrogenase release [24] . POVPC induced lactate dehydrogenase release in a dose-and time-dependent manner in BMDMs (Supplemental Fig. 1A-D) , showing that pyroptosis is accompanied by POVPC-induced inflammasome activation.
To further delineate the activation of the inflammasome by POVPC, we examined how the addition of POVPC before, during, and after priming with LPS affects inflammasome activation. Pretreatment with POVPC before LPS priming did not induce IL-1b secretion in BMDMs (Supplemental Fig. 2A ). In addition, simultaneous treatment of POVPC with LPS priming did not induce IL-1b secretion in BMDMs (Supplemental Fig. 2B ). When POVPC was treated after LPS priming, an increase of IL-1b secretion was observed (Supplemental Fig. 2C ). These findings suggest that the priming signal is necessary for POVPC to induce activation of the inflammasome.
The activation of pattern recognition receptors by lipids has been reported. Oxidized LDL and other lipids, including saturated fatty acids, activate TLRs [25] [26] [27] and the NLRP3 inflammasome [28, 29] . To investigate whether POVPC alone would be sufficient to induce the priming signal (pro-IL-1b induction), BMDMs were treated with POVPC, and the levels of pro-IL-1b mRNA were determined. The induction of pro-IL-1b mRNA by POVPC was much weaker than that induced by LPS (Supplemental Fig. 3A) . Similarly, the immunoblot analysis showed that pro-IL-1b production induced by POVPC was very weak, as compared with that induced by LPS (Supplemental Fig. 3B ). Neither POVPC alone nor LPS alone was sufficient to induce the degradation of procaspase-1 to caspase-1(p10) and cleavage of pro-IL-1b to IL-1b (Supplemental Fig. 3B ). POVPC alone did not induce secretion of IL-1b as assessed by ELISA (Supplemental Fig. 3C ). The results show that POVPC without priming signal is not sufficient to induce the production of mature IL-1b. We examined whether other oxPAPCs induce the activation of the inflammasome in macrophages. KOdiA-PC induced the degradation of procaspase-1 and pro-IL-1b to caspase-1(p10) and IL-1b, respectively, in BMDMs, in a dose-and time-dependent manner, as determined by immunoblot analysis (Supplemental Fig. 4A, B) . The secretion of IL-1b was also increased by KOdiA-PC, as assessed by ELISA (Supplemental Fig. 4C, D) . In addition, KOdiA-PC induced oligomerization of ASC in BMDMs (Supplemental Fig. 4E, F) . PGPC also induced the production of caspase-1(p10) and IL-1b in a dose-and time-dependent manner in BMDMs, as determined by immunoblot analysis and ELISA (Supplemental Fig. 5A-D) . These results show that in addition to POVPC, other oxPAPCs such as KOdiA-PC and PGPC, can induce the activation of the inflammasome in macrophages.
POVPC-induced production of caspase-1 and IL-1b is abolished in caspase-1-knockout macrophages A pan-caspase inhibitor, Z-VAD, blocked POVPC-induced secretion of mature IL-1b in BMDMs (Fig. 3A) . POVPC failed to induce the cleavage of pro-IL-1b to IL-1b in BMDMs derived from caspase-1-deficient mice, when compared with wild-type BMDMs (Fig. 3B) . The secretion of mature IL-1b induced by POVPC was greatly diminished in caspase-1-deficient BMDMs (Fig. 3C) . Similarly, ATP, a positive control, induced the cleavage of pro-IL-1b to IL-1b and the secretion of IL-1b in wild-type BMDMs, but not caspase-1-deficient BMDMs (Fig. 3B, C) .
These results indicate that the production of IL-1b by POVPC is dependent on caspase-1 in macrophages.
POVPC-induced activation of the inflammasome requires NLRP3
To investigate whether NLRP3 is involved in POVPC-induced inflammasome activation, POVPC was added to BMDMs derived from NLRP3-deficient mice. POVPC-induced degradation of procaspase-1 to caspase-1 and cleavage of pro-IL-1b to IL-1b were markedly diminished in NLRP3-deficient BMDMs (Fig. 4A) . In addition, the secretion of IL-1b induced by POVPC was abolished in NLRP3-deficient BMDMs (Fig. 4C) . Production of caspase-1 and IL-1b induced by ATP, a positive control, was abolished in NLRP3-deficient BMDMs, whereas poly(dA:dT), an absent in melanoma (AIM)-2 inflammasome activator, was able to induce production of caspase-1 and IL-1b in NLRP3-deficient BMDMs (Fig. 4B, D) . Similarly, the production of caspase-1(p10) and IL-1b by KOdiA-PC was abolished in NLRP3-deficient BMDMs (Supplemental Fig. 6 ). The results showed that NLRP3 is essential for inflammasome activation by oxPAPCs, such as POVPC and KOdiA-PC in macrophages.
We further investigated the in vivo activation of the NLRP3 inflammasome by POVPC, in an air pouch mouse model that Jin et al. [30] used to demonstrate hydroxyapatite-induced activation of the NLRP3 inflammasome by measuring neutrophil infiltration and IL-1b production in air pouch lavage fluid. POVPC was injected into an air pouch in wild-type and NLRP3-deficient mice and the production of caspase-1(p10), IL-1b, and IL-18, which are the indicators of inflammasome activation, was measured in the air pouch lavage fluid. POVPC injection resulted in the production of caspase-1(p10) and IL-1b in the air pouch of wildtype mice, as determined by immunoblot analysis (Fig. 5A) . ELISA of air pouch fluids confirmed that POVPC induced the production of IL-1b and IL-18 in wild-type mice (Fig. 5B, C) . In contrast, POVPC failed to induce the production of caspase-1 (p10), IL-1b, and IL-18 in the air pouch of NLRP3-deficient mice (Fig. 5A-C) .
In addition, we investigated the in vivo activation of the NLRP3 inflammasome by POVPC in a mouse peritonitis model with MSU crystals serving as a positive control. The peritoneal injection of POVPC into wild-type mice induced the increase of IL-1b and -18 in peritoneal lavage fluid, similar to injection of MSU (Fig. 5D, E) . The induction of IL-1b and -18 secretion by POVPC or MSU was greatly diminished in NLRP3-deficient mice (Fig. 5D, E) . The results demonstrate the in vivo activation of the NLRP3 inflammasome by POVPC in the mouse peritonitis model.
These results demonstrate that POVPC induces the activation of the NLRP3 inflammasome, in both cell system and in vivo mouse models.
POVPC-induced inflammasome activation is mediated by intracellular Ca
2+ flux, but not the potassium efflux and phagocytosis pathways
We investigated the underlying mechanism as to how POVPC induces the activation of the NLRP3 inflammasome. The cellular mechanisms of NLRP3 inflammasome activation include the potassium efflux, the release of cathepsin B from lysosome, and the increase in cytosolic calcium level [31] [32] [33] . Addition of extracellular KCl (100 mM) inhibited ATP-induced generation of caspase-1(p10) and IL-1b (Supplemental Fig. 7A, B) , whereas POVPC-induced inflammasome activation was not suppressed by the addition of KCl (Fig. 6A, B) . These results suggest that the potassium efflux is not involved in POVPC-induced NLRP3 inflammasome activation.
Next, we examined whether POVPC-induced NLRP3 inflammasome activation is mediated by cathepsin B release from the lysosome in BMDMs. The phagocytosis inhibitor (cytochalasin D) or cathepsin B inhibitor (CA-074-Me) suppressed MSU-induced production of caspase-1(p10) and IL-1b (Supplemental Fig. 7C-F) . In contrast, POVPC-induced production of caspase-1(p10), and IL-1b was not inhibited by cytochalasin D or cathepsin B inhibitor (Fig. 6C-F) . These results suggest that POVPC-induced NLRP3 inflammasome activation is not mediated by the phagocytosis pathway or by release of cathepsin B. We further investigated whether Ca 2+ flux was a contributor to POVPC-mediated inflammasome activation. Treatment of U73122, a phospholipase C inhibitor, blocked POVPC-induced IL-1b secretion in BMDMs (Fig. 6G) . Consistently, 2-APB, an inositol trisphosphate receptor inhibitor, resulted in the reduction of POVPC-induced IL-1b secretion in BMDMs (Fig. 6H) . Both U73122 and 2-APB blocked ATP-induced IL-1b secretion in BMDMs (Supplemental Fig. 7G, H) . These results show that intracellular Ca 2+ signaling is involved in POVPC-induced inflammasome activation in macrophages.
POVPC-induced inflammasome activation is mediated through mitochondrial ROS
It has been reported that an increase in cytosolic Ca 2+ promotes mitochondrial Ca 2+ uptake, resulting in mitochondrial Ca 2+ overload and enhancing oxidative phosphorylation followed by increased mitochondrial ROS production [32, 34] . Mitochondrial ROS is attributable to the activation of the NLRP3 inflammasome [35] . We investigated whether POVPC induces the production of mitochondrial ROS in BMDMs. POVPC increased the level of mitochondrial ROS in BMDMs, as determined by fluorescence assay with MitoSOX (Fig. 7A,  B) . Confocal microscopic analysis also showed the increased production of mitochondrial ROS by POVPC in BMDMs (Fig.  7C, D) . The NADPH oxidase inhibitors DPI and APDC suppressed POVPC-induced production of caspase-1(p10) and IL-1b in BMDMs (Fig. 8A-C) . DPI blocked the production of mitochondrial ROS by POVPC in BMDMs (Fig. 8D, E) . Similarly, ATP-induced production of mitochondrial ROS was inhibited by DPI (Fig. 8F, G) . The suppression of inflammasome activation by DPI correlated with the blockade of POVPC-induced mitochondrial ROS production. DPI and APDC cotreatment did not significantly change cellular viability compared with POVPC treatment alone, as determined by MTT assay (Supplemental Fig. 8 ). These results suggest that POVPC-induced NLRP3 inflammasome activation is mediated through mitochondrial ROS production in macrophages.
Mitochondrial Ca 2+ overload also induces mitochondrial destabilization [36] , which in turn promotes mitochondrial ROS production by disrupting electron transport [37] . Shimada et al. [38] reported that CsA, a mitochondrial stabilizing agent, attenuates ATP-induced IL-1b secretion in macrophages, suggesting that mitochondrial destabilization is linked to NLRP3 inflammasome activation. We investigated whether mitochondrial destabilization is involved in POVPCinduced inflammasome activation. CsA reduced POVPCinduced IL-1b secretion in BMDMs (Fig. 9A) , by blocking ATP-induced IL-1b secretion (Fig. 9B) . The results suggest that POVPC treatment results in mitochondrial destabilization, leading to the activation of inflammasome in macrophages.
DISCUSSION
In this study, our results demonstrate that endogenously produced oxidized phospholipids such as POVPC induce the secretion of IL-1b in macrophages through the activation of the NLRP3 inflammasome. Other studies have shown that endogenous lipid products, such as saturated fatty acid, ceramide, cholesterols, and oxidized LDL, induced the activation of the NLRP3 inflammasome and the production of IL-1b [6, 10] . Our results indicate that oxidized phospholipids may exert the proinflammatory activity by activating the NLRP3 inflammasome and thereby promoting the production of the inflammatory cytokine IL-1b. Because it has been reported that oxidized phospholipids, including POVPC, accumulate highly in various pathologic sites such as atherosclerosis, hyperlipidemia, dyslipidemia, and nonalcoholic fatty liver disease [15, 16] , it is possible that oxidized phospholipids are involved in the development and progress of these diseases by activating the NLRP3 inflammasome and inducing the secretion of IL-1b.
There are reports showing that OxPAPCs such as 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphorylcholine exhibit anti-inflammatory effects. von Schlieffen et al. [39] reported that pretreatment of oxPAPCs, including POVPC and PGPC, resulted in the decrease of E-selectin expression induced by LPS in HUVECs. Erridge et al. [40] showed that cotreatment of POVPC and PGPC inhibited induction of NFkB activation in response to Pam3CSK4 and LPS in HEK-293 cells expressing TLR-2 or -4, respectively. KOdiA-PC has been reported to suppress TLR4 activation by inhibiting LPS binding to MD2 in macrophages [41] . These findings show the inhibitory effect of oxPAPC on TLR activation. However, there is some evidence that oxPAPCs exert proinflammatory effects.
OxPAPCs induced the synthesis of various cytokines and chemokines, such as IL-1b, IL-8, and MCP-1, in macrophages and vascular smooth muscle cells [13, 14] and up-regulated the expression of IL-6 and TNF-a in osteoblasts [42] . POVPC increased monocyte binding to endothelial cells by inducing the surface expression of the connecting segment 1 domain of fibronectin while it inhibited LPS-induced neutrophil binding and expression of E-selectin [12] . PGPC induced both monocyte and neutrophil binding and increased the expression of E-selectin and VCAM-1 [12] . It is suggested that the controversial effects of oxPAPC, either anti-or proinflammatory, is dependent on the concentration of the lipids [43] . Proinflammatory effects may be observed more in local sites of lipid accumulation with relatively higher concentration ranges. OxPAPCs are mainly produced at the site of oxidative stress in vivo, such as within atherosclerotic lesions and plasma in dyslipidemia. Especially, POVPC and PGPC accumulated in atherogenic-diet-fed rabbit aortas (183.1 6 54.5 and 104.2 6 26.3 mg/g wet tissue weight, respectively), compared with levels in aortas from normal-diet-fed rabbit (41.6 6 7.0 and 35.3 6 5.5 mg/g wet tissue weight, respectively) [18] . Our results show that inflammasome activation by POVPC and PGPC in the cells was prominently observed at 50-100 mg/ml, which may be achieved at local sites of inflammatory tissues. A temporal encounter with POVPC may determine activation or suppression of inflammatory responses, as well. Addition of POVPC after LPS priming, but not before or during priming, resulted in the secretion of IL-1b in macrophages suggesting that cells must be exposed to the priming signal before exposure to POVPC. The inflamed or diseased environment that generates inflammatory priming signals may exacerbate the proinflammatory activity of POVPC. Therefore, these results suggest that oxPAPCs act as endogenous danger signals to stimulate the activation of inflammasome at a highly stressed and oxidized state, contributing to the development and progress of lipid-associated diseases.
In contrast to oxidized LDL, which activated the NLRP3 inflammasome mediated through phagocytosis and the lysosome rupture pathway [28] , POVPC-induced NLRP3 inflammasome activation was not dependent on cathepsin B released by lysosome rupture. Mitochondrial ROS are produced by NLRP3 activators and considered to be critical for NLRP3 inflammasome activation [44] . POVPC induced the production of mitochondrial ROS, contributing to the activation of NLRP3 inflammasome by POVPC. The suppression of ROS production by NADPH oxidase inhibitors resulted in the blockade of mitochondrial ROS production and NLRP3 inflammasome activation induced by POVPC, suggesting the involvement of NADPH oxidase.
Our collective results reveal the novel mechanism of how oxidized phosphatidylcholines induce the secretion of IL-1b and exert proinflammatory activity. To our best knowledge, this is the first investigation to show the activation of NLRP3 inflammasome by oxidized phosphatidylcholine. The results could provide an insight into how the oxidized lipids endogenously produced by cellular stress and tissue damage can 
